Fulcrum Equity Management Decreases Holdings in AbbVie Inc. (NYSE:ABBV)

Fulcrum Equity Management lowered its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 10.7% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 7,205 shares of the company’s stock after selling 862 shares during the quarter. AbbVie comprises 1.2% of Fulcrum Equity Management’s investment […]

Leave a Reply

Your email address will not be published.

Previous post dentalcorp (TSE:DNTL) Given a C$12.00 Price Target by TD Securities Analysts
Next post Match Group (NASDAQ:MTCH) Given New $30.00 Price Target at Loop Capital